Search

everythinglearnresearchcommunity

for

Search:↓

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

PRP injections improved facial aesthetics in most women, but more research is needed.

Using quantitative traits in genetics can improve understanding and management of skin health and conditions.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Platelet-rich plasma (PRP) is effective and safe for improving skin appearance.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Acne is linked to complex skin microbe interactions, and new findings suggest microbiome-based treatments could be effective.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

The mutation causing Hutchinson-Gilford progeria syndrome leads to severe skin problems and early death in mice.

Personalized acne treatments and new therapies show promise for better results.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

New mutations in hair keratin genes can change hair structure and cause monilethrix, with nail issues more common in certain gene mutations.

Cholesterol affects coronavirus spread and could be a target for treatment.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

MSC-derived exosomes may help in skin repair and regeneration.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Skin inflammation can worsen intestinal inflammation and colitis.

Scleroderma patients have lower hair miR-29a levels.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Treatments with sunscreen and active ingredients can reduce skin hyperpigmentation by decreasing DNA methylation.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Lasers can trigger skin reactions, especially in darker skin, and more research is needed to improve treatments.

Rosacea severely affects the quality of life for many patients in China, especially young adults and those with appearance-related jobs.